Health Technology · Pharmaceuticals: Major · NSE: INDOCO · data 2026-10-09
Indoco Remedies Limited
Health check: Weak (2.7/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹230.7
Market cap
₹2,187 cr
P/E
377.5
P/B
—
ROE
-9.7%
ROCE
-2.0%
Debt / equity
1.15
Dividend yield
0.08%
1-year return
-21.7%
52-week high
₹317.35
52-week low
₹162.19
Operating margin
1.8%
Growth
| Revenue (last 12 months) | ₹1,873 cr |
| Net profit (last 12 months) | ₹6 cr |
| Sales growth, 3 years (yearly) | 3.0% |
| Profit growth, 3 years (yearly) | — |
Chart patterns
- Double top — breakdown (key level ₹235)
Similar companies
Venus Remedies Limited (VENUSREM) · Syncom Formulation (India) Ltd. (SYNCOMF) · Sai Parenterals Limited (SAIPARENT) · Sakar Healthcare Ltd (SAKAR) · Panacea Biotec Limited (PANACEABIO)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open INDOCO in NSE Scanner →